47 related articles for article (PubMed ID: 38555412)
1. Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Ye Y; Labopin M; Gérard S; Yakoub-Agha I; Blau IW; Aljurf M; Forcade E; Gedde-Dahl T; Burns D; Vydra J; Halahleh K; Hamladji RM; Bazarbachi A; Nagler A; Brissot E; Li L; Luo Y; Zhao Y; Ciceri F; Huang H; Mohty M; Gorin NC
Am J Hematol; 2024 Jul; 99(7):1290-1299. PubMed ID: 38654658
[TBL] [Abstract][Full Text] [Related]
2. Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Abid MB; Estrada-Merly N; Zhang MJ; Chen K; Bredeson C; Allan D; Sabloff M; Marks DI; Litzow M; Hourigan C; Kebriaei P; Saber W
Transplant Cell Ther; 2023 Oct; 29(10):611-618. PubMed ID: 37481243
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.
Acevedo MJ; Wilder JS; Adams S; Davis J; Kelly C; Hilligoss D; Carroll E; Blacklock-Schuver B; Cole K; Kang EM; Hsu AP; Kanakry CG; Dimitrova D; Kanakry JA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1666-1673. PubMed ID: 30986499
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party.
El Cheikh J; Ngoya M; Galimard JE; Reményi P; Kulagin A; Aljurf M; Mousavi A; Wu D; Ozcelik T; Salmenniemi U; Castilla-Llorente C; Socie G; Helbig G; Schroeder T; Sakellari I; Rambaldi A; Burt R; Busca A; Balsat M; Stelljes M; Brissot E; Giebel S; Peric Z; Nagler A; Bazarbachi A; Ciceri F; Mohty M
Bone Marrow Transplant; 2024 Jun; ():. PubMed ID: 38834689
[TBL] [Abstract][Full Text] [Related]
5. Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT.
Sanz J; Labopin M; Blaise D; Raiola AM; Busca A; Vydra J; Tischer J; Chevallier P; Bramanti S; Fanin R; Socié G; Forcade E; Kröger N; Koc Y; Itäla-Remes M; Zecca M; Nagler A; Brissot E; Spyridonidis A; Bazarbachi A; Giebel S; Piemontese S; Mohty M; Ciceri F
Blood Adv; 2024 May; 8(10):2332-2341. PubMed ID: 38429091
[TBL] [Abstract][Full Text] [Related]
6. Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Ngoya M; Galimard JE; Labopin M; Blau IW; Kröger N; Gedde-Dahl T; Schroeder T; Burns D; Salmenniemi U; Rambaldi A; Choi G; Peffault de Latour R; Vydra J; Sengeloev H; Eder M; Mielke S; Forcade E; Kulagin A; Ciceri F; Mohty M
Am J Hematol; 2024 Jun; ():. PubMed ID: 38856236
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors.
Herr MM; Balderman SR; Wallace PK; Zhang Y; Tario JD; Buxbaum NP; Holtan S; Ross M; McCarthy PL; Betts B; Maslak P; Hahn TE
Transplant Cell Ther; 2024 May; ():. PubMed ID: 38801976
[TBL] [Abstract][Full Text] [Related]
8. Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis.
Ye Y; Wang M; Malard F; Shi J; Lu Y; Ouyang G; Lan J; Tan Y; Zhao Y; Yu J; Lai X; Wu Y; Yang L; Gao F; Mohty M; Huang H; Luo Y
Bone Marrow Transplant; 2021 Oct; 56(10):2567-2574. PubMed ID: 34031554
[TBL] [Abstract][Full Text] [Related]
9. Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT.
Ye Y; Labopin M; Chen J; Wu D; Gedde-Dahl T; Blaise D; Socie G; Forcade E; Salmenniemi U; Maury S; Versluis J; Bazarbachi A; Nagler A; Brissot E; Li L; Luo Y; Shi J; Ciceri F; Huang H; Mohty M; Gorin NC
Blood Cancer J; 2024 May; 14(1):85. PubMed ID: 38802349
[No Abstract] [Full Text] [Related]
10. Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia.
Ronnacker J; Urbahn MA; Reicherts C; Kolloch L; Berning P; Sandmann S; Eßeling E; Call S; Floeth M; Marx J; Albring J; Mikesch JH; Schliemann C; Lenz G; Stelljes M
Br J Haematol; 2024 Jun; ():. PubMed ID: 38831752
[TBL] [Abstract][Full Text] [Related]
11. Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
Kaida K; Ikegame K; Inoue T; Maruyama S; Ishii S; Uchida N; Doki N; Eto T; Fukuda T; Katayama Y; Takada S; Kawakita T; Ichinohe T; Atsuta Y; Daimon T; Ogawa H
Transplant Cell Ther; 2023 Apr; 29(4):273.e1-273.e9. PubMed ID: 36641032
[TBL] [Abstract][Full Text] [Related]
12. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M
Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557
[TBL] [Abstract][Full Text] [Related]
13. Survival After Hematopoietic Stem Cell Transplantation in Severe Combined Immunodeficiency (SCID): A Worldwide Review of the Prognostic Variables.
Goebel GA; de Assis CS; Cunha LAO; Minafra FG; Pinto JA
Clin Rev Allergy Immunol; 2024 Apr; ():. PubMed ID: 38689103
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Maffini E; Labopin M; Kröger N; Finke J; Stelljes M; Schroeder T; Einsele H; Tischer J; Bornhäuser M; Bethge W; Brecht A; Rösler W; Dreger P; Schäfer-Eckart K; Passweg J; Blau IW; Nagler A; Ciceri F; Mohty M
Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38555412
[TBL] [Abstract][Full Text] [Related]
15. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Maffini E; Ngoya M; Galimard JE; Harbi S; Kröger N; Platzbecker U; Sengeloev H; Craddock C; Potter V; Choi G; Chevallier P; Stölzel F; Tholouli E; Maertens J; Ciceri F; Cornelissen J; Sanz J; Spyridonidis A; Lanza F; Nagler A; Mohty M
Bone Marrow Transplant; 2023 Sep; 58(9):1033-1041. PubMed ID: 37386253
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
